Rock Springs Capital Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14M | Sell |
|
|||||
|
2025
Q2 | $14.1M | Buy |
|
|||||
|
2025
Q1 | $9.17M | Buy |
|
|||||
|
2024
Q4 | $9.64M | Hold |
|
|||||
|
2024
Q3 | $10.9M | Hold |
|
|||||
|
2024
Q2 | $10M | Hold |
|
|||||
|
2024
Q1 | $7.54M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.92M | Hold |
|
|||||
|
2022
Q2 | $1.03M | Hold |
|
|||||
|
2022
Q1 | $1.58M | Buy |
|
|||||
|
2021
Q4 | $1.9M | Buy |
|
|||||
|
2021
Q3 | $3.38M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $7.95M | Buy |
|
|||||
|
2020
Q3 | $7.3M | Sell |
|
|||||
|
2020
Q2 | $10.1M | Sell |
|
|||||
|
2020
Q1 | $7.15M | Buy |
|